CTLA4 and nonpapillary renal cell carcinoma: In the current work, we attempted to comprehensively analyze the prognostic value of CTLA4 in ccRCC and its impact on TILs and genetic landscape through bioinformatics and in vitro experiment, which may be beneficial to the therapeutic response of CTLA4 inhibitors in ccRCC patients.